Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Clinical Lung Cancer|June 5, 2012
Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases BoardSteven C Kao, Janette Vardy, Mark Chatfield, et al.
Epigenomics|May 18, 2016
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerGlen Reid, Steven C Kao, Nick Pavlakis, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 23, 2008
Patient and physician preferences for surgical and adjuvant treatment options for rectal cancerJames D Harrison, Michael J Solomon, Jane M Young, et al.
Asia-Pacific Journal of Clinical Oncology|September 24, 2020
Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigationAlexander Yuile, Claudia Fanuli, Sheryl van Nunen, et al.
Clinical Lung Cancer|October 23, 2012
Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesotheliomaSteven C H Kao, Kenneth Lee, Sonja Klebe, et al.
Molecular and Clinical Oncology|July 15, 2015
Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case reportDavid Chan, Stephen Clarke, Anthony J Gill, et al.
Veterinary Surgery : VS|June 25, 2011
Postoperative complications after surgical management of incomplete ossification of the humeral condyle in dogsRachel Hattersley, Malcolm McKee, Turlough O'Neill, et al.
Neuroendocrinology|November 12, 2019
High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine NeoplasmsDavid L Chan, Elizabeth J Bernard, Geoffrey Schembri, et al.
ANZ Journal of Surgery|March 30, 2024
National screening for colorectal cancer is associated with stage shift to earlier diagnosisMina Sarofim, Amir Ashrafizadeh, Anthony J Gill, et al.
Clinical Colorectal Cancer|September 2, 2006
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicityPaul L Mitchell, David Goldstein, Michael Michael, et al.
Pageof 21